STOCK TITAN

Hyperfine to Present at the 2022 Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Hyperfine (Nasdaq: HYPR) announced that management will present at the 2022 Jefferies Global Healthcare Conference on June 8 at 4:00 PM EDT. The event will feature Dave Scott, President and CEO, and Alok Gupta, CFO.

Interested parties can access a live and archived webcast through the company’s website in the “Investors” section. Hyperfine is known for creating Swoop, the world’s first FDA-cleared portable MRI system, which enhances patient access to rapid diagnoses in various clinical settings.

Positive
  • None.
Negative
  • None.

GUILFORD, Conn., May 25, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that management will be presenting at the upcoming 2022 Jefferies Global Healthcare Conference in New York, New York.

Dave Scott, President and CEO, and Alok Gupta, CFO, are scheduled to present on Wednesday, June 8 at 4:00 PM EDT. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.hyperfine.io.

About Hyperfine
Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the world’s first FDA-cleared portable MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments (ED), operating rooms (OR) outside the sterile field, and intensive care units (ICU), among others.

Investor Contact
Marissa Bych
Gilmartin Group LLC
marissa@gilmartinir.com

Media Contact
Aunny De La Rosa-Bathe
APCO Worldwide
abathe@apcoworldwide.com


FAQ

When will Hyperfine present at the 2022 Jefferies Global Healthcare Conference?

Hyperfine will present on June 8, 2022, at 4:00 PM EDT.

Who is presenting for Hyperfine at the conference?

Dave Scott, President and CEO, and Alok Gupta, CFO, will present for Hyperfine.

How can I access the webcast of Hyperfine's presentation?

The webcast can be accessed live and archived in the 'Investors' section of Hyperfine's website.

What is Hyperfine's stock symbol?

Hyperfine's stock symbol is HYPR.

What is Swoop by Hyperfine?

Swoop is the world's first FDA-cleared portable MRI system designed to enhance patient access to rapid diagnosis.

Hyperfine, Inc.

NASDAQ:HYPR

HYPR Rankings

HYPR Latest News

HYPR Stock Data

66.75M
52.43M
9.5%
24.35%
2.14%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GUILFORD